The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 620.00
Bid: 610.00
Ask: 630.00
Change: -6.00 (-0.96%)
Spread: 20.00 (3.279%)
Open: 620.00
High: 620.00
Low: 615.00
Prev. Close: 626.00
ELIX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Feb 2021 08:00

RNS Number : 2879O
Elixirr International PLC
08 February 2021
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Trading Update

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, is pleased to provide an update on trading for the year ended 31 December 2020.

Trading since our last update in October 2020 has continued to be strong. The Group has continued to support its clients to address their key challenges, with Elixirr's services in relation to digital transformation and innovation in high demand.

Subject to the completion of the audit for the year ended 31 December 2020, the Group expects to record revenue of approximately £30m, ahead of the market expectation of £29.4m. On an IAS 17 basis, Adjusted EBITDA is expected to be approximately £9m, slightly ahead of the market expectation of £8.9m. On an IFRS 16 basis, Adjusted EBITDA is expected to be approximately £9.6m.

As at 31 December 2020, the Group had no debt with cash balances totalling £17.5m.

The Group has continued to make good progress on all four of its strategic growth pillars, including:

· Stretching our current partner team - we achieved organic revenue growth of 20% in 2020

· Promoting partners from within the firm - an experienced principal with deep banking experience was promoted to partner on 1 January 2021

· Hiring new partners - an experienced partner with deep strategy and innovation experience joined on 1 January 2021 to accelerate the growth of our US business

· Buying complementary businesses - we are pleased with the performance of Coast Digital Limited since acquisition in October 2020, where it took us just one week to sell their services into one of our current clients and where we see a strong pipeline throughout 2021. In addition, we are continuing to explore a number of other attractive acquisition opportunities.

The Group has made a strong start to 2021, recording another record revenue month in January 2021, following three record revenue months during 2020. Including the impact of the Coast Digital acquisition, the Directors expect Q1 revenue to increase by more than 50% compared to Q1 2020.

Commenting on the trading update, Stephen Newton, CEO, said:

"I am very proud of the financial results that we have achieved in our first year as a public company. We have delivered significant growth in revenue and profit against the backdrop of one of the most uncertain and challenging business environments many of us have experienced in our careers. Our success reflects the intersection of three critical factors. The most crucial factor is the results we continually deliver for our clients. A team of dedicated and entrepreneurial partners whose economic interests are 100% aligned with our high-quality shareholder base, empower this performance. As a result, we have a strong pipeline of exciting opportunities in 2021 and are confident of further growth in revenue and profit."

The Group has repaid the grants received during 2020 from the UK Government's Coronavirus Job Retention (Furlough) Scheme.

The full year results for the year ended 31 December 2020 will be announced on 12 April 2021 and the Directors look forward to providing a more detailed update to shareholders at that time.

 

 

For further Information please contact:

Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO

 

 

 

 

Public and Investor Relations contacts:

Caroline Pitt

Jazz Berry

 

finnCap Ltd (Nominated Adviser & Sole Broker)

Christopher Raggett, Simon Hicks, Kate Bannatyne (Corporate Finance)

Alice Lane, Sunila De Silva (ECM)

 

 

 

investor-relations@elixirr.com

 

 +44 (0)20 7220 0500

 

 

   

About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

The information communicated in this announcement includes inside information for the purposes of Article 7 Regulation 596/2014.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWSBRAVUURRR
12
Date   Source Headline
24th Apr 20247:00 amRNSGrant of Share Options
22nd Apr 20247:00 amRNSFinal Results
8th Apr 20247:00 amRNSNotice of FY 23 Results and Investor Presentation
26th Jan 20247:00 amRNSDirector Dealing
8th Jan 20247:00 amRNSTrading Update and Change to Dividend Policy
11th Dec 20237:00 amRNSAcquisition of Insigniam LLC and Insigniam SAS
18th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSAcquisition of Responsum, Inc.
13th Jun 202310:45 amRNSResult of AGM
24th May 20231:31 pmRNSHolding(s) in Company
19th May 20237:00 amRNSPosting of Annual Report and Accounts
10th May 20233:00 pmRNSDirector/PCA Dealings
26th Apr 20237:00 amRNSGrant of Share Options
12th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20233:00 pmRNSDirector Dealing
3rd Apr 20239:15 amRNSDirector Dealing
3rd Apr 20237:00 amRNSFinal Results
28th Mar 20237:00 amRNSInvestor Presentation
27th Feb 20239:05 amRNSSecond Price Monitoring Extn
27th Feb 20239:00 amRNSPrice Monitoring Extension
27th Feb 20237:00 amRNSTrading Update
24th Feb 20232:05 pmRNSSecond Price Monitoring Extn
24th Feb 20232:00 pmRNSPrice Monitoring Extension
24th Feb 202311:05 amRNSSecond Price Monitoring Extn
24th Feb 202311:00 amRNSPrice Monitoring Extension
29th Nov 20221:15 pmRNSInvestor Presentation
11th Nov 20227:00 amRNSDirector Dealing
20th Oct 20227:00 amRNSPCA Dealing
6th Oct 20227:00 amRNSPurchase of Shares by Employee Benefit Trust
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension
11th Jul 20221:45 pmRNSPDMR/PCA Dealing
7th Jul 202211:15 amRNSPCA Dealing
13th Jun 20221:00 pmRNSResult of AGM
19th May 20227:00 amRNSPosting of Annual Report & Accounts
29th Apr 20224:07 pmRNSResult of Secondary Placing
28th Apr 20224:06 pmRNSProposed Secondary Placing
8th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSAcquisition of iOLAP and FY2022 Earnings
1st Feb 20227:00 amRNSTrading Update
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 202111:41 amRNSResult of Secondary Placing
13th Oct 20217:00 amRNSProposed Secondary Placing
27th Sep 20217:00 amRNSInterim Results
17th Jun 20218:13 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.